ABCC1 and neoplasm: Tumor suppressor miR-128 sensitized breast cancers to DOX by targeting ABCC5, while the overexpression of miR-145 suppressed ABCC1/MRP1 to overcome DOX resistance in breast cancers [45,194,195].